EUVIMEDEUVIMED entdecken
Crossref

Pharmacological Inhibition of Hexokinase 2 Impairs Hematoma Clearance and Exacerbates Brain Injury After Intracerebral Hemorrhage in Mice

Jinyu Dai, Yuxin Xie, Ye Yuan, Zhongyi Zhang, Linhui Zhang, Zongyi Xie, Yihao Tao

Translational Stroke Research · 2026

DOI: 10.1007/s12975-026-01508-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Stroke Research, 2026. Verfasst von Jinyu Dai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, 76 Linjiang Road, Chongqing, 400010, China. Hauptthemen laut MEDLINE: Hexokinase, Cerebral Hemorrhage, Hematoma, Enzyme Inhibitors. Die Arbeit nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission, Chongqing Medical Leading Talents Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Erythrocyte-derived metabolites released from the hematoma contribute substantially to secondary brain injury after intracerebral hemorrhage (ICH), and enhancing endogenous hematoma clearance is a promising therapeutic strategy. Hexokinase 2 (HK2), a key glycolytic enzyme predominantly expressed in microglia, regulates microglial function, but its role in hematoma resolution after ICH remains unclear. We therefore investigated whether HK2 governs microglia/macrophage-mediated erythrophagocytosis and thereby influences hematoma clearance and neurological recovery after ICH. ICH was induced in male C57BL/6 mice by striatal collagenase injection, and HK2 was selectively inhibited with 3-bromopyruvate (3-BP). Neurobehavioral outcomes, hematoma volume, and hemoglobin content were quantified, and mechanisms were examined in hemoglobin- or erythrocyte-stimulated BV2 microglia and RAW 264.7 macrophages using pharmacological inhibition, glucose-6-phosphate (G-6-P) rescue, and lentiviral HK2 overexpression. After ICH, HK2 was localized predominantly to peri-hematomal microglia/macrophages, and nuclear HK2 increased progressively, peaking at 72 h. HK2 inhibition exacerbated neurological deficits, reduced M2-like (Arg-1⁺) microglia/macrophages, and delayed hematoma clearance without affecting initial hematoma formation. In vitro, G-6-P restored ATP levels suppressed by 3-BP but only partially rescued phagocytosis, indicating a non-glycolytic mechanism: HK2 upregulated peroxisome proliferator-activated receptor γ (PPARγ) and CD36, and pharmacological blockade of PPARγ abolished HK2-enhanced erythrophagocytosis. These findings identify HK2 as a contributor to endogenous hematoma clearance that promotes microglia/macrophage erythrophagocytosis at least in part through PPARγ/CD36 signaling, and support further genetic and cell-specific studies before HK2 is advanced as a therapeutic target for ICH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HexokinaseCerebral HemorrhageHematomaEnzyme InhibitorsBrain InjuriesAnimalsMaleMice, Inbred C57BLMiceMicrogliaPyruvatesMacrophagesDisease Models, Animal

Stichwörter der Autor:innen

Hematoma clearanceHexokinase 2Intracerebral hemorrhageMicroglia/macrophageerythrophagocytosis

Substanzen

HexokinasePyruvateshexokinase 2, mousebromopyruvateEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, 76 Linjiang Road, Chongqing, 400010, China.
  • Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, 76 Linjiang Road, Chongqing, 400010, China. zyxie2008@cqmu.edu.cn.
  • Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, 76 Linjiang Road, Chongqing, 400010, China. tyheva@cqmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission
  • Chongqing Medical Leading Talents Program
  • Kuanren Talents Program of the Second Affiliated Hospital of Chongqing Medical University
  • Chongqing Postdoctoral Science Foundation

Zitieren

APA

Dai, J., Xie, Y., Yuan, Y., Zhang, Z., Zhang, L., Xie, Z., & Tao, Y. (2026). Pharmacological Inhibition of Hexokinase 2 Impairs Hematoma Clearance and Exacerbates Brain Injury After Intracerebral Hemorrhage in Mice. Translational Stroke Research. https://doi.org/10.1007/s12975-026-01508-8

Vancouver

Dai J, Xie Y, Yuan Y, Zhang Z, Zhang L, Xie Z, et al. Pharmacological Inhibition of Hexokinase 2 Impairs Hematoma Clearance and Exacerbates Brain Injury After Intracerebral Hemorrhage in Mice. Translational Stroke Research. 2026. doi:10.1007/s12975-026-01508-8

BibTeX
@article{Dai2026,
  author = {Dai, Jinyu and Xie, Yuxin and Yuan, Ye and Zhang, Zhongyi and Zhang, Linhui and Xie, Zongyi and Tao, Yihao},
  title = {Pharmacological Inhibition of Hexokinase 2 Impairs Hematoma Clearance and Exacerbates Brain Injury After Intracerebral Hemorrhage in Mice},
  journal = {Translational Stroke Research},
  year = {2026},
  doi = {10.1007/s12975-026-01508-8}
}
Kostenlos starten →